EVAN BENJAMIN DREYER
Medical Practice in Pittsburgh, PA
License number
Pennsylvania MD062408L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Pittsburgh, PA 15241
Personal information
See more information about EVAN BENJAMIN DREYER at radaris.comName
Address
Phone
2180 Truxton Dr, Pittsburgh, PA 15241
220 Bessemer Rd, Mt Pleasant, PA 15666
Bethel Park, PA
39 Market St, Philadelphia, PA 19019
39 Market St, Philadelphia, PA 19019
Professional information
Evan B Dreyer, Pittsburgh PA
Specialties:
Ophthalmologist
Address:
1145 Bower Hill Rd, Pittsburgh, PA 15243
Education:
Harvard Medical School - Doctor of Medicine
Massachusetts Eye & Ear Infirmary - Fellowship - Glaucoma
Massachusetts Eye & Ear Infirmary - Residency - Ophthalmology
Massachusetts Eye & Ear Infirmary - Fellowship - Glaucoma
Massachusetts Eye & Ear Infirmary - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Dr. Evan B Dreyer, Mount Pleasant PA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Mount Pleasant Surgery Center
200 Bessemer Rd, Mount Pleasant 15666
(724) 547-5432 (Phone)
Glaucoma Cataract Consultants
1145 Bower Hill Rd SUITE 205, Pittsburgh 15243
(412) 572-6121 (Phone)
Glaucoma Cataract Consultants
17 Arentzen Blvd SUITE 201, Charleroi 15022
(724) 483-3688 (Phone)
Glaucoma Cataract Consultants
220 Bessemer Rd SUITE 101, Mount Pleasant 15666
(724) 547-5733 (Phone)
220 Dessner Rd, Mount Pleasant 15666
200 Bessemer Rd, Mount Pleasant 15666
(724) 547-5432 (Phone)
Glaucoma Cataract Consultants
1145 Bower Hill Rd SUITE 205, Pittsburgh 15243
(412) 572-6121 (Phone)
Glaucoma Cataract Consultants
17 Arentzen Blvd SUITE 201, Charleroi 15022
(724) 483-3688 (Phone)
Glaucoma Cataract Consultants
220 Bessemer Rd SUITE 101, Mount Pleasant 15666
(724) 547-5733 (Phone)
220 Dessner Rd, Mount Pleasant 15666
Certifications:
Ophthalmology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1984
Bellevue Hospital Center
Mass Eye & Ear Infirm
Harvard Medical School
Graduated: 1984
Bellevue Hospital Center
Mass Eye & Ear Infirm
Director, Glaucoma At Glaucoma Cataract Consultants
Position:
Director, glaucoma at Glaucoma cataract consultants
Location:
Greater Pittsburgh Area
Industry:
Medical Practice
Work:
Glaucoma cataract consultants
-
Director, glaucoma
Calcium Blockers To Treat Proliferative Vitreoretinopathy
US Patent:
6573280, Jun 3, 2003
Filed:
Jan 2, 2002
Appl. No.:
10/038215
Inventors:
Evan B. Dreyer - Pittsburgh PA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31445
US Classification:
514317, 514656, 514912
Abstract:
Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy. Avoidance or management of proliferative vitreoretinopathy can be achieved by administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration.
Calcium Blockers To Treat Proliferative Vitreoretinopathy
US Patent:
7230032, Jun 12, 2007
Filed:
May 12, 2003
Appl. No.:
10/436902
Inventors:
Evan B. Dreyer - Pittsburgh PA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/135
US Classification:
514656, 514912
Abstract:
Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy. Avoidance or management of proliferative vitreoretinopathy can be achieved by administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration.
Calcium Blockers To Treat Proliferative Vitreoretinopathy
US Patent:
8101635, Jan 24, 2012
Filed:
Jul 6, 2004
Appl. No.:
10/885422
Inventors:
Evan B. Dreyer - Pittsburgh PA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/445, A61K 31/135
US Classification:
514317, 514646, 514912
Abstract:
Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy. Avoidance or management of proliferative vitreoretinopathy can be achieved by administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration.